Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L8KJ
|
||||
Former ID |
DIB002837
|
||||
Drug Name |
Oglemilast
|
||||
Synonyms |
GRC-3886; Oglemilast (oral, COPD/asthma), Glenmark
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Asthma [ICD10:J45] | Phase 2 | [522312] | ||
Company |
Glenmark Pharmaceuticals Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C20H13Cl2F2N3O5S
|
||||
Canonical SMILES |
c1(ccc2c(c1)c1c(o2)c(ccc1C(=O)Nc1c(cncc1Cl)Cl)OC(F)F)NS<br />(=O)(=O)C
|
||||
CAS Number |
CAS 778576-62-8
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | CAMP-specific 3',5'-cyclic phosphodiesterase 4A | Target Info | Inhibitor | [544060] | |
CAMP-specific 3',5'-cyclic phosphodiesterase 4B | Target Info | Inhibitor | [544060] | ||
Type IV phosphodiesterase | Target Info | Inhibitor | [544060] | ||
NetPath Pathway | IL5 Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
PathWhiz Pathway | Purine Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.